NeoImmuneTech, Inc. (NIT or “NeoImmuneTech”), a clinical-stage T cell-focused biopharmaceutical company, today announced they have become a member of the United Nations (UN) Global Compact. The participation to this global, strategic initiative illustrates NIT’s commitment to responsible business practices in the areas of human rights, labor, the environment, and corruption.
The UN Global Compact is a voluntary initiative based on CEOs’ commitments to implement universal sustainability principles and to take steps to support UN goals. It regroups 19,000+ organizations and companies from 165 countries.
By becoming a member of the UN Global Compact principles, NIT accepts and will take actions to support the Ten Principles of the UN Global Compact and the Sustainable Development Goals (SDGs). This new milestone underlines NIT’s strong commitment to Environmental, Social, and Governance (ESG) Principles that have become an increasingly important part of any investment process and a matter of critical importance for many shareholders.
Media inquiries : firstname.lastname@example.org